Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...

Patient advocate Barbara Moss joins Inspire2Live's international fight to make cancer drugs available to people in poorer countries like Africa ...

Chemotherapy drugs in over 100 countries fail quality tests, putting cancer patients at risk of ineffective treatments.